What do Irish experts think about controversial ADHD claims?

A prominent psychiatrist and media commentator, Dr Max Pemberton, recently sparked controversy after completing an online ADHD assessment and declaring himself diagnosed with the condition for a Channel Four documentary titled The Great ADHD Myth?. His actions, along with the documentary’s portrayal of a 10-year-old boy named Mason, have ignited heated debate among Irish mental health professionals and advocates. According to the Irish Times, Pemberton's self-diagnosis and subsequent use of ADHD medication have raised questions about the ease with which individuals can secure a formal diagnosis, even through non-traditional means. Pemberton’s documentary features Mason, whose family opted to remove him from ADHD medication for six weeks. During this period, the child was observed engaging in environmental changes such as reduced screen time, increased physical activity, and dietary adjustments. While Mason reportedly felt more like himself during this phase, his teacher noted that he became more talkative and disruptive in class. The documentary includes expert commentary suggesting skepticism toward ADHD as a legitimate medical disorder and questioning the role of pharmaceutical companies in shaping diagnostic trends. Dr Iona Heath, former president of the Royal College of General Practitioners, called for a complete reassessment of how ADHD is understood and treated, advocating for systemic educational reforms that prioritize creativity and movement over medication. Prof Matthew Smyth, a professor of health history at Strathclyde University, further challenged the notion of ADHD as a biological condition, describing it as a “social construct.” He argued that the rising number of diagnoses aligns with the growing influence of pharmaceutical companies, which profit from the production and marketing of ADHD medications. Such views contrast sharply with those of Sarah Cassidy, president of the Psychological Society of Ireland, who condemned the documentary as “offensive to ADHDers, irresponsible and harmful.” Cassidy, who has been diagnosed with autism, dyspraxia, and ADHD, emphasized that the goal of an ADHD assessment is not to assign a label but to identify necessary support systems. She warned that untreated ADHD increases the risk of substance abuse, risky behaviors, and other complications. The documentary also highlights the broader implications of the ADHD diagnosis landscape. Dr Margo Wrigley, a consultant psychiatrist and national clinical lead for ADHD in the Health Service Executive (HSE), noted that the pandemic led to a surge in ADHD assessments. Many individuals struggled to maintain focus or productivity in home environments, leading to increased interest in potential treatments. This trend underscores the complex interplay between societal pressures, individual experiences, and medical understanding of ADHD. The discussion around ADHD extends beyond clinical settings into public perception and policy. Experts like Heath and Smyth argue for a shift away from pharmacological interventions toward holistic approaches that address environmental factors and behavioral patterns. However, advocacy groups and clinicians like Cassidy stress that such perspectives often overlook the lived realities of those with ADHD. For many, the condition presents genuine challenges that require tailored support rather than broad generalizations. As the conversation continues, the debate over ADHD diagnosis and treatment reflects deeper tensions within healthcare, education, and public discourse. With conflicting viewpoints emerging from both sides of the argument, the path forward will likely involve ongoing dialogue, research, and policy reform aimed at balancing scientific inquiry with compassionate care.